Investigators conducted a retrospective study to better understand whether there is an equally shared risk for C difficile infection across immunosuppressant classes.
The NDA submission was supported by data from the phase 3 SURE1 clinical trial.
Dalvance is a second-generation, semi-synthetic lipoglycopeptide.
A multidisciplinary panel comprising members from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America created guidelines for health care professionals caring for patients with C difficile infection.
Kimyrsa is a single-dose, long-acting lipoglycopeptide antibiotic.
There were 101 Candida auris cases at a nursing home and 22 cases at hospitals from January to April.
The purpose of the study was to compare a composite clinical failure outcome of 60-day readmission, 60-day recurrence, and mortality in patients treated for MRSA with dual therapy vs those de-escalated to monotherapy.
Vaxneuvance consists of pneumococcal polysaccharides from 15 serotypes, including serotypes 22F and 33F.
The association was observed with colon cancer but not rectal cancer.
Rapid-Seal is an antibacterial hemostatic wound gel designed to control minor bleeding and seal minor cuts and scrapes.
